Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Our knowledge of the pathophysiology of affect dysregulation has progressively increased, but the pharmacological treatments remain inadequate. Here, we summarize the current literature on deficits in somatostatin, an inhibitory modulatory neuropeptide, in major depression and other neurological disorders that also include mood disturbances. We focus on direct evidence in the human postmortem brain, and review rodent genetic and pharmacological studies probing the role of the somatostatin system in relation to mood. We also briefly go over pharmacological developments targeting the somatostatin system in peripheral organs and discuss the challenges of targeting the brain somatostatin system. Finally, the fact that somatostatin deficits are frequently observed across neurological disorders suggests a selective cellular vulnerability of somatostatin-expressing neurons. Potential cell intrinsic factors mediating those changes are discussed, including nitric oxide induced oxidative stress, mitochondrial dysfunction, high inflammatory response, high demand for neurotrophic environment, and overall aging processes. Together, based on the co-localization of somatostatin with gamma-aminobutyric acid (GABA), its presence in dendritic-targeting GABA neuron subtypes, and its temporal-specific function, we discuss the possibility that deficits in somatostatin play a central role in cortical local inhibitory circuit deficits leading to abnormal corticolimbic network activity and clinical mood symptoms across neurological disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 1×
“…refined cellular www.frontiersin.org September 2013 | Volume 4 | Article 110 | 5 “fphar-04-00110” — 2013/9/5 — 15:44 — page 6 — #6 definition, from Brainbow (Livet et al., 2007) to CLARITY (Chung et al., 2013) and SeeDB (Ke et al., 2013), across different developmental stages may help identify…”
BackgroundA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 2×
““fphar-04-00110” — 2013/9/5 — 15:44 — page 1 — #1 REVIEW ARTICLE published: 09 September 2013 doi: 10.3389/fphar.2013.00110 Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?”
BackgroundInfluentialInflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 2×
“Evidence for low levels of CSF somatostatin was found to correlate significantly with elevated urinary cortisol in MDD patients (Molchan et al., 1993).”
BackgroundWhy do many psychiatric disorders emerge during adolescence?
Paus, T., Keshavan, M., & Giedd, J. N. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2513 · Cited by 3,123 · cited 1×
“Although many mood disorders emerge during adolescence (Paus et al., 2008), behavioral abnormalities including affect dysregulation are often heritable and apparent before diagnostic criteria are met (McGuffin et al., 2003; Geller et al., 2006).”
BackgroundTREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 1×
“…is associated with increased risk in Alzheimer’s disease progression and additive effect with the APOE epsilon4 allele (Vepsalainen et al., 2007; Xue et al., 2009), although this was not confirmed in larger genome-wide association studies (GWAS) (Hollingworth et al., 2011; Guerreiro et al., 2013).”
Interneurons of the neocortical inhibitory system
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1519 · Cited by 2,954 · cited 2×
“…reviews have summarized the role of the somatostatin system, including in receptor subtypes (Patel, 1999; Csaba and Dournaud, 2001), pharmacological developments (Neggers and van der Lely, 2009), and during normal and pathological aging (Patel, 1999; Viollet et al., 2008; Martel et al., 2012).”
BackgroundAssociations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Structural and molecular interrogation of intact biological systems
Chung, K., Wallace, J., Kim, S.-Y., Kalyanasundaram, S., Andalman, A. S., Davidson, T. J., Mirzabekov, J. J., Zalocusky, K. A., Mattis, J., Denisin, A. K., et al. (2013) · Nature · doi:10.1038/nature12107 · Cited by 2,008
Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997 · cited 2×
“…is associated with increased risk in Alzheimer’s disease progression and additive effect with the APOE epsilon4 allele (Vepsalainen et al., 2007; Xue et al., 2009), although this was not confirmed in larger genome-wide association studies (GWAS) (Hollingworth et al., 2011; Guerreiro et al., 2013).”
Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system
Livet, J., Weissman, T. A., Kang, H., Draft, R. W., Lu, J., Bennis, R. A., Sanes, J. R., & Lichtman, J. W. (2007) · Nature · doi:10.1038/nature06293 · Cited by 1,876
Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons
Rudy, B., Fishell, G., Lee, S., & Hjerling‐Leffler, J. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20853 · Cited by 1,420
GABAergic cell subtypes and their synaptic connections in rat frontal cortex
Kawaguchi, Y. (1997) · Cerebral Cortex · doi:10.1093/cercor/7.6.476 · Cited by 1,416 · cited 2×
“Somatostatin is a modulatory neuropeptide that synergizes with GABA-mediated inhibition, and that specifically targets the distal dendritic compartment of pyramidal neurons in cortical local circuits (Kawaguchi and Kubota, 1997; Gentet et al., 2012).”
BackgroundThe Heritability of Bipolar Affective Disorder and the Genetic Relationship to Unipolar Depression
McGuffin, P., Rijsdijk, F., Andrew, M., Sham, P., Katz, R., & Cardno, A. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.5.497 · Cited by 1,243
Davies, P., Katzman, R., & Terry, R. D. (1980) · Nature · doi:10.1038/288279a0 · Cited by 882 · cited 1×
“…somatostatin immune-reactivity across cortical and subcortical regions is reported in subjects with Alzheimer’s disease, including temporal cortex, frontal cortex, and hippocampus (Davies et al., 1980; Rossor et al., 1980; Davies and Terry, 1981; Candy et al., 1985; Dournaud et al., 1994).”
BackgroundIL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress
Koo, J. W., & Duman, R. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708092105 · Cited by 862
New insights into the classification and nomenclature of cortical GABAergic interneurons
DeFelipe, J., López-Cruz, P. L., Benavides-Piccione, R., Bielza, C., Larrañaga, P., Anderson, S., Burkhalter, A., Cauli, B., Fairén, A., Feldmeyer, D., et al. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3444 · Cited by 833
Goshen, I., Kreisel, T., Ben-Menachem-Zidon, O., Licht, T., Weidenfeld, J., Ben-Hur, T., & Yirmiya, R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002055 · Cited by 762
Age-related inflammatory cytokines and disease
Brüünsgaard, H., & Pedersen, B. K. (2003) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(02)00056-5 · Cited by 608
Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume.
Erickson, K. I., Prakash, R. S., Voss, M. W., Chaddock, L., Heo, S., McLaren, M., Pence, B. D., Martin, S. A., Vieira, V. J., Woods, J. A., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6251-09.2010 · Cited by 604
Lee, S., Hjerling-Leffler, J., Zagha, E., Fishell, G., & Rudy, B. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1869-10.2010 · Cited by 600
Two dynamically distinct inhibitory networks in layer 4 of the neocortex
Beierlein, M., Gibson, J. R., & Connors, B. W. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00283.2003 · Cited by 591
Division and subtraction by distinct cortical inhibitory networks in vivo
Wilson, N. R., Runyan, C. A., Wang, F. L., & Sur, M. (2012) · Nature · doi:10.1038/nature11347 · Cited by 568 · cited 2×
“…interneurons preferentially target distal dendrites of pyramidal neurons in layer 2/3 to modulate the processing of incoming sensory information before it is integrated at the soma level (Di Cristo et al., 2004; Markram et al., 2004; Tan et al., 2008; Murayama et al., 2009; Xu et al., 2013).”
BackgroundMaes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.014 · Cited by 544
Cruikshank, S. J., Urabe, H., Nurmikko, A. V., & Connors, B. W. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.025 · Cited by 459
Unique functional properties of somatostatin-expressing GABAergic neurons in mouse barrel cortex
Gentet, L. J., Kremer, Y., Taniguchi, H., Huang, Z. J., Staiger, J. F., & Petersen, C. C. H. (2012) · Nature Neuroscience · doi:10.1038/nn.3051 · Cited by 438
Rajkowska, G., O'Dwyer, G., Teleki, Z., Stockmeier, C. A., & Miguel-Hidalgo, J. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301234 · Cited by 430 · cited 12×
“The route and characterization, however, from CSF somatostatin to MDD pathophysiology is not direct, potentially due to a paucity of information on factors regulating CSF somatostatin, and to inconclusive somatostatin/HPA axis studies in MDD patients.”
ResultInfluentialXu, X., Roby, K. D., & Callaway, E. M. (2010) · Journal of Comparative Neurology · doi:10.1002/cne.22229 · Cited by 429
GABAergic Interneurons Shape the Functional Maturation of the Cortex
Le Magueresse, C., & Monyer, H. (2013) · Neuron · doi:10.1016/j.neuron.2013.01.011 · Cited by 425
Leach, L. S., Christensen, H., Mackinnon, A. J., Windsor, T. D., & Butterworth, P. (2008) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-008-0388-z · Cited by 413 · cited 1×
“…in community-based epidemiological studies, where the factor of seeking treatment is removed (Kornstein et al., 2000; Festinger et al., 2008; Leach et al., 2008) and findings of low somatostatin in the amygdala appear more robust in postmortem studies of female MDD subjects (Tripp et al.,…”
BackgroundIncrease of plasma IL-6 concentration with age in healthy subjects
Wei, J., Xu, H., Davies, J. L., & Hemmings, G. P. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90112-3 · Cited by 402 · cited 1×
“Repeated administration of imipramine, maprotiline, mianserin, carbamazepine or zotepine has no effect on somatostatin levels in various brain regions of rats (Weiss et al., 1987; Kakigi et al., 1992).”
BackgroundGuilloux, J.-P., Douillard-Guilloux, G., Kota, R., Wang, X., Gardier, A. M., Martinowich, K., Tseng, G. C., Lewis, D. A., & Sibille, E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.113 · Cited by 378 · cited 3×
“…brainderived neurotrophic factor (Bdnf) knockout or disruption of exon IV-expressing Bdnf transcripts show decreased somatostatin gene expression (Glorioso et al., 2006; Martinowich et al., 2011; Guilloux et al., 2012), demonstrating that somatostatin expression depends on Bdnf signaling.”
BackgroundSelf-citationGonchar, Y. (2008) · Frontiers in Neuroanatomy · doi:10.3389/neuro.05.003.2007 · Cited by 369 · cited 1×
“…et al., 2010; Rudy et al., 2011), and 40–50% of GABA neurons contain parvalbumin without overlapping with somatostatin in the frontal cortex, primary somatosensory cortex and visual cortex of mouse (Gonchar et al., 2007; Xu et al., 2010) and the visual cortex of rat (Gonchar and Burkhalter, 1997).”
BackgroundDendritic encoding of sensory stimuli controlled by deep cortical interneurons
Murayama, M., Pérez-Garci, E., Nevian, T., Bock, T., Senn, W., & Larkum, M. E. (2009) · Nature · doi:10.1038/nature07663 · Cited by 369 · cited 1×
“…interneurons preferentially target distal dendrites of pyramidal neurons in layer 2/3 to modulate the processing of incoming sensory information before it is integrated at the soma level (Di Cristo et al., 2004; Markram et al., 2004; Tan et al., 2008; Murayama et al., 2009; Xu et al., 2013).”
BackgroundNeocortical Somatostatin-Expressing GABAergic Interneurons Disinhibit the Thalamorecipient Layer 4
Xu, H., Jeong, H.-Y., Tremblay, R., & Rudy, B. (2013) · Neuron · doi:10.1016/j.neuron.2012.11.004 · Cited by 366
Padmos, R. C., Hillegers, M. H. J., Knijff, E. M., Vonk, R., Bouvy, A., Staal, F. J. T., de Ridder, D., Kupka, R. W., Nolen, W. A., & Drexhage, H. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.395 · Cited by 336
Compartmentalization of GABAergic inhibition by dendritic spines
Chiu, C. Q., Lur, G., Morse, T. M., Carnevale, N. T., Ellis-Davies, G. C. R., & Higley, M. J. (2013) · Science · doi:10.1126/science.1234274 · Cited by 307
Hippocampal interneurons are abnormal in schizophrenia
Konradi, C., Yang, C. K., Zimmerman, E. I., Lohmann, K. M., Gresch, P., Pantazopoulos, H., Berretta, S., & Heckers, S. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.007 · Cited by 288
Tripp, A., Oh, H., Guilloux, J.-P., Martinowich, K., Lewis, D. A., & Sibille, E. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12020248 · Cited by 273 · cited 6×
“Interestingly, these somatostatin deficits were systematically more robust in female subjects across cohorts and regions (Sibille et al., 2011; Tripp et al., 2011, 2012; Guilloux et al., 2012), consistent with the female heightened vulnerability to develop MDD, and suggesting that low somatostatin…”
BackgroundInfluentialSelf-citationMolecular aging in human prefrontal cortex is selective and continuous throughout adult life
Erraji-Benchekroun, L., Underwood, M. D., Arango, V., Galfalvy, H., Pavlidis, P., Smyrniotopoulos, P., Mann, J. J., & Sibille, E. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.034 · Cited by 236
Self-citationGABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders
Sibille, E., Morris, H. M., Kota, R. S., & Lewis, D. A. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001616 · Cited by 217
Self-citationReduced somatostatin in subgenual anterior cingulate cortex in major depression
Tripp, A., Kota, R. S., Lewis, D. A., & Sibille, E. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.014 · Cited by 190
Self-citationThe relevance of oxidative stress status in first episode and recurrent depression
Stefanescu, C., & Ciobica, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.022 · Cited by 179
Robust but delayed thalamocortical activation of dendritic-targeting inhibitory interneurons
Tan, Z., Hu, H., Huang, Z. J., & Agmon, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710628105 · Cited by 155 · cited 2×
“…| Neuropharmacology September 2013 | Volume 4 | Article 110 | 4 “fphar-04-00110” — 2013/9/5 — 15:44 — page 5 — #5 Dournaud, 2001; Di Cristo et al., 2004; Markram et al., 2004; Tan et al., 2008; Fishell and Rudy, 2011; Gentet et al., 2012; DeFelipe et al., 2013; Le Magueresse and Monyer, 2013).”
BackgroundWang, A. Y., Lohmann, K. M., Yang, C. K., Zimmerman, E. I., Pantazopoulos, H., Herring, N., Berretta, S., Heckers, S., & Konradi, C. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0881-4 · Cited by 135 · cited 2×
“Studies in subjects with bipolar disorder indicate decreases in somatostatin cellular density in the caudal entorhinal cortex and parasubiculum (Wang et al., 2011), number of somatostatin-expressing neurons in the hippocampus (Konradi et al., 2011b), somatostatin gene expression in the dlPFC (trend…”
BackgroundHippocampal Interneurons in Bipolar Disorder
Konradi, C., Zimmerman, E. I., Yang, C. K., Lohmann, K. M., Gresch, P., Pantazopoulos, H., Berretta, S., & Heckers, S. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.175 · Cited by 115
Depression following pegylated interferon-alpha: Characteristics and vulnerability
Lotrich, F. E., Rabinovitz, M., Gironda, P., & Pollock, B. G. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2007.05.013 · Cited by 100
Anticipated brain molecular aging in major depression
Douillard-Guilloux, G., Guilloux, J.-P., Lewis, D. A., & Sibille, E. (2013) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.040 · Cited by 62
Self-citationPredator Stress Induces Behavioral Inhibition and Amygdala Somatostatin Receptor 2 Gene Expression
Nanda, S. A., Qi, C., Roseboom, P. H., & Kalin, N. H. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00401.x · Cited by 55 · cited 1×
“In line with the observed changes in Sst2KO mice, acute predator stress in rats led to up-regulated Sst2 gene expression in the amygdala and cingulate cortex, shown correlated with Fos expression in the amygdala (Nanda et al., 2008).”
Background
Cited by
Cortical gamma band synchronization through somatostatin interneurons
Veit, J., Hakim, R., Jadi, M. P., Sejnowski, T. J., & Adesnik, H. (2017) · Nature Neuroscience · doi:10.1038/nn.4562 · Cited by 381
Fee, C., Banasr, M., & Sibille, E. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.024 · Cited by 329
Self-citationMa, K., Xu, A., Cui, S., Sun, M.-R., Xue, Y.-C., & Wang, J.-H. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.181 · Cited by 168
Berretta, S., Pantazopoulos, H., Markota, M., Brown, C., & Batzianouli, E. T. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.040 · Cited by 152
“to be altered in psychiatric disorders (McDonald and Mascagni, 2006; Volk et al., 2012; Lin and Sibille, 2013; Fung et al., 2014; Volk and Lewis, 2014).”
Soumier, A., & Sibille, E. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.76 · Cited by 136
“In MDD, converging evidence suggests a contribution of decreased GABA to the altered excitation/inhibition balance, as observed by proton magnetic resonance spectroscopy studies or by transcranial magnetic stimulation (Bajbouj et al, 2006; Hasler et al, 2007; Levinson et al, 2010; Sanacora et al, 1999; Sanacora et al,…”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Lin, L.-C., & Sibille, E.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 4
- Pages
- 110-110
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2009346831
- Cited by
- 116
- References
- 49
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.